Search results
Showing results for
People with Rheumatoid Arthritis (RA) could soon benefit from a new drug treatment that not only suppresses inflammation but also significantly reduces patient reported pain scores. Otilimab is a monoclonal antibody, biologic drug, which targets and suppresses the inflammatory cytokine GM-CSF.
Kadoorie Institute for Trauma, Emergency and Critical Care
The Kadoorie Institute designs and tests innovative treatments and care pathways that improve patient outcomes and deliver more efficient healthcare. By combining resources and expertise across Trauma, Emergency and Critical Care, the Institute accelerates this research.
OxKen
The Oxford Kennedy MB PhD (BM DPhil) Educational Training Program
Meet Chris
-
Christopher Buckley
Kennedy Professor of Translational Rheumatology and Director of Clinical Research
